Collaboration is the key to drug development. In The Medicine Maker’s recent article, our chief commercial officer Brian Powl shares his thoughts on efficient cross-collaboration, including involving various professional parties early on in the #drugdevelopment process to optimize each step along the way. Read the full piece, including additional insights here: https://lnkd.in/g9bNdXZd
Driving Innovations in Preclinical Oncology and Immuno-Oncology Research
4wThis approach not only enhances efficiency but also drives innovation and better outcomes in the drug development journey. Great read!